SCHEMBL235607

SCHEMBL235607

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC(O)[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 8/20 0.77
CASP7 P55210 3/20 0.77
HSD17B10 Q99714 3/20 0.77
TDP1 Q9NUW8 3/20 0.77
EPHA2 P29317 3/20 0.77
VDR P11473 3/20 0.77
TP53 P04637 2/20 0.77
MAPK1 P28482 2/20 0.77
BLM P54132 2/20 0.77
NR1H4 Q96RI1 2/20 0.77
AKR1B10 O60218 2/20 0.77
AKR1B1 P15121 2/20 0.77
LMNA P02545 2/20 0.77
USP2 O75604 2/20 0.77
MAPT P10636 2/20 0.77
MDM4 O15151 1/20 0.77
CYP3A4 P08684 1/20 0.77
HSPD1 P10809 1/20 0.77
TSHR P16473 1/20 0.77
PTPN2 P17706 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL235606 1.00 GPBAR1 (0.77) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL26670009 1.00 GPBAR1 (0.77) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL1697153 0.91 GPBAR1 (0.76) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL1697152 0.91 GPBAR1 (0.76) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL476518 0.89 GPBAR1 (0.73) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL1653772 0.89 GPBAR1 (0.79) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL476519 0.89 GPBAR1 (0.73) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL5577556 0.89 GPBAR1 (0.73) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL5577551 0.89 GPBAR1 (0.73) GPBAR1CASP7HSD17B10TDP1EPHA2
SCHEMBL26601017 0.89 GPBAR1 (0.62) GPBAR1CASP7HSD17B10TDP1EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210088539-A1 AUTOMATED SAMPLE QUALITY ASSESSMENT METABOLON, INC. 2021-03-25 US disclosed
US-8679457-B2 Metabolite biomarkers to distinguish Crohn's disease from ulcerative colitis and methods using the same METABOLON, INC. (US) 2014-03-25 US disclosed
US-20120003158-A1 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same METABOLON, INC. 2012-01-05 US disclosed
EP-1080103-A4 COMPOSITIONS AND METHODS FOR NON-PARENTERAL DELIVERY OF OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2003-07-02 EP disclosed
EP-1080103-A1 COMPOSITIONS AND METHODS FOR NON-PARENTERAL DELIVERY OF OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2001-03-07 EP disclosed
WO-1999060012-A1 COMPOSITIONS AND METHODS FOR NON-PARENTERAL DELIVERY OF OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 1999-11-25 WO disclosed